G01N 2333/095
Rhinovirus
G01N2333/095 (Rhinovirus) appears on 13 US grants and 22 published applications in this corpus.
Search patents in G01N- Granted patents
- 13
- Published applications
- 22
- Assignees
- 17
- Inventors
- 61
- Latest grant
- 25 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 1 | 1 |
| 2010 | 0 | 2 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 1 | 1 |
| 2019 | 2 | 3 |
| 2020 | 1 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 1 | 3 |
| 2025 | 2 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for assessing antibody specificities25 Mar 2025US 12,259,396 B2Serimmune Inc.
- Nasopharyngeal protein biomarkers of acute respiratory virus infection and methods of using same11 Mar 2025US 12,247,977 B2Duke University
- Methods and compositions for assessing antibody specificities19 Nov 2024US 12,146,884 B2Serimmune Inc.
- Methods and compositions for assessing antibody specificities28 Nov 2023US 11,828,762 B2Serimmune Inc.
- Methods and compositions for assessing antibody specificities22 Dec 2020US 10,871,494 B2Serimmune Inc.
- System and method of identification of a specific alkylamide for the treatment of respiratory virus infections23 Apr 2026US 2026/0110696 A1Sonoran University of Health Sciences
- Dual-system method for assessing transmissibility and disease severity of respiratory viruses25 Sep 2025US 2025/0298008 A1Centre for Immunology & Infection Limted
- System and composition of respiratory organoids for progagation of viruses and methods thereof14 Aug 2025US 2025/0257325 A1Centre for Virology, Vaccinology and Therapeutics Limited
- Methods and compositions for assessing antibody specificities5 Dec 2024US 2024/0402189 A1Serimmune Inc.
- General affinity epitope polypeptide for human rhinovirus, and antibody and uses thereof24 Oct 2024US 2024/0350615 A1Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Most cited
By later US patents
- Methods and compositions for assessing antibody specificities3US 10,386,373 B2Serimmune Inc. · 2019
- Enzymatic diagnostic test for SARS and other viral diseases3US 7,635,557 B2MND Diagnostic Ltd. · 2009
- Methods of propagating rhinovirus C in previously unsusceptible cell lines2US 10,280,405 B2Wisconsin Alumni Research Foundation · 2019
- Methods of propagating rhinovirus C in previously unsusceptible cell lines2US 9,938,507 B2Wisconsin Alumni Research Foundation · 2018
- Antiviral agents1US 7,371,755 B1Biota Scientific Management Pty Ltd. · 2008